240 related articles for article (PubMed ID: 9216635)
1. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
Jakowlew SB; Moody TW; Mariano JM
Anticancer Res; 1997; 17(3C):1849-60. PubMed ID: 9216635
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
[TBL] [Abstract][Full Text] [Related]
3. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.
Kim IY; Ahn HJ; Zelner DJ; Shaw JW; Sensibar JA; Kim JH; Kato M; Lee C
Cancer Res; 1996 Jan; 56(1):44-8. PubMed ID: 8548772
[TBL] [Abstract][Full Text] [Related]
4. Concurrent and distinct transcription and translation of transforming growth factor-beta type I and type II receptors in rodent embryogenesis.
Mariano JM; Montuenga LM; Prentice MA; Cuttitta F; Jakowlew SB
Int J Dev Biol; 1998 Nov; 42(8):1125-36. PubMed ID: 9879710
[TBL] [Abstract][Full Text] [Related]
5. The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP.
Kim IY; Zelner DJ; Lee C
Exp Cell Res; 1998 May; 241(1):151-60. PubMed ID: 9633523
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
7. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
Guo Y; Kyprianou N
Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta receptor expression in human cornea.
Joyce NC; Zieske JD
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):1922-8. PubMed ID: 9331255
[TBL] [Abstract][Full Text] [Related]
9. Expression of transforming growth factor beta ligand and receptor messenger RNAs in lung cancer cell lines.
Jakowlew SB; Mathias A; Chung P; Moody TW
Cell Growth Differ; 1995 Apr; 6(4):465-76. PubMed ID: 7794814
[TBL] [Abstract][Full Text] [Related]
10. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.
Joyce NC; Harris DL; Mello DM
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2152-9. PubMed ID: 12091410
[TBL] [Abstract][Full Text] [Related]
12. Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone.
Kim IY; Zelner DJ; Sensibar JA; Ahn HJ; Park L; Kim JH; Lee C
Exp Cell Res; 1996 Jan; 222(1):103-10. PubMed ID: 8549651
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
Miyafuji Y; Zhong X; Uchida I; Koi M; Hemmi H
J Cell Physiol; 2001 Jun; 187(3):356-64. PubMed ID: 11319759
[TBL] [Abstract][Full Text] [Related]
14. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma.
Ripley D; Tang XM; Ma C; Chegini N
Gynecol Oncol; 2001 May; 81(2):301-9. PubMed ID: 11330966
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas.
Piestrzeniewicz-Ulanska D; Brys M; Semczuk A; Rechberger T; Jakowicki JA; Krajewska WM
Gynecol Oncol; 2004 Oct; 95(1):173-80. PubMed ID: 15385128
[TBL] [Abstract][Full Text] [Related]
16. Reduced transforming growth factor-beta type II receptor (TGF-beta RII) expression in adenocarcinoma of the lung.
Kim WS; Park C; Jung YS; Kim HS; Han J; Park CH; Kim K; Kim J; Shim YM; Park K
Anticancer Res; 1999; 19(1A):301-6. PubMed ID: 10226558
[TBL] [Abstract][Full Text] [Related]
17. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.
Vincent F; Nagashima M; Takenoshita S; Khan MA; Gemma A; Hagiwara K; Bennett WP
Oncogene; 1997 Jul; 15(1):117-22. PubMed ID: 9233784
[TBL] [Abstract][Full Text] [Related]
18. Insufficient TGF-beta 1 production inactivates the autocrine growth suppressive circuit in human ovarian cancer cell lines.
Zeinoun Z; Teugels E; De Bleser PJ; Neyns B; Geerts A; De Greve J
Anticancer Res; 1999; 19(1A):413-20. PubMed ID: 10226576
[TBL] [Abstract][Full Text] [Related]
19. Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells.
Yang HK; Kang SH; Kim YS; Won K; Bang YJ; Kim SJ
Oncogene; 1999 Apr; 18(13):2213-9. PubMed ID: 10327067
[TBL] [Abstract][Full Text] [Related]
20. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells.
Lu S; Dong Z
Prostate; 2006 Jun; 66(9):996-1004. PubMed ID: 16541418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
